187 related articles for article (PubMed ID: 1688510)
41. Synthesis of peptide and pseudopeptide amides inhibiting the proliferation of small cell and epithelial types of lung carcinoma cells.
Nyéki O; Rill A; Schon I; Orosz A; Schrett J; Bartha L; Nagy J
J Pept Sci; 1998 Dec; 4(8):486-95. PubMed ID: 9927255
[TBL] [Abstract][Full Text] [Related]
42. In vitro effects of substance P analogue [D-Arg1, D-Phe5, D-Trp7,9, Leu11] substance P on human tumour and normal cell growth.
Everard MJ; Macaulay VM; Miller JL; Smith IE
Br J Cancer; 1992 Mar; 65(3):388-92. PubMed ID: 1373071
[TBL] [Abstract][Full Text] [Related]
43. Increased gastrin-releasing peptide (GRP) receptor expression in tumour cells confers sensitivity to [Arg6,D-Trp7,9,NmePhe8]-substance P (6-11)-induced growth inhibition.
Waters CM; MacKinnon AC; Cummings J; Tufail-Hanif U; Jodrell D; Haslett C; Sethi T
Br J Cancer; 2003 Jun; 88(11):1808-16. PubMed ID: 12771999
[TBL] [Abstract][Full Text] [Related]
44. New short-chain analogs of a substance-P antagonist inhibit proliferation of human small-cell lung-cancer cells in vitro and in vivo.
Orosz A; Schrett J; Nagy J; Bartha L; Schön I; Nyéki O
Int J Cancer; 1995 Jan; 60(1):82-7. PubMed ID: 7529212
[TBL] [Abstract][Full Text] [Related]
45. Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer.
Cuttitta F; Carney DN; Mulshine J; Moody TW; Fedorko J; Fischler A; Minna JD
Nature; 1985 Aug 29-Sep 4; 316(6031):823-6. PubMed ID: 2993906
[TBL] [Abstract][Full Text] [Related]
46. High-affinity receptors for peptides of the bombesin family in Swiss 3T3 cells.
Zachary I; Rozengurt E
Proc Natl Acad Sci U S A; 1985 Nov; 82(22):7616-20. PubMed ID: 2999772
[TBL] [Abstract][Full Text] [Related]
47. Small cell lung cancer bombesin receptors are antagonized by reduced peptide bond analogues.
Mahmoud S; Palaszynski E; Fiskum G; Coy DH; Moody TW
Life Sci; 1989; 44(5):367-73. PubMed ID: 2536883
[TBL] [Abstract][Full Text] [Related]
48. Substance P analogues function as bombesin receptor antagonists and inhibit small cell lung cancer clonal growth.
Bepler G; Zeymer U; Mahmoud S; Fiskum G; Palaszynski E; Rotsch M; Willey J; Koros A; Cuttitta F; Moody TW
Peptides; 1988; 9(6):1367-72. PubMed ID: 2470067
[TBL] [Abstract][Full Text] [Related]
49. [D-Arg1,D-Phe5,D-Trp7,9,Leu11]Substance P acts as a biased agonist toward neuropeptide and chemokine receptors.
Jarpe MB; Knall C; Mitchell FM; Buhl AM; Duzic E; Johnson GL
J Biol Chem; 1998 Jan; 273(5):3097-104. PubMed ID: 9446627
[TBL] [Abstract][Full Text] [Related]
50. High affinity receptors for bombesin/GRP-like peptides on human small cell lung cancer.
Moody TW; Carney DN; Cuttitta F; Quattrocchi K; Minna JD
Life Sci; 1985 Jul; 37(2):105-13. PubMed ID: 2409423
[TBL] [Abstract][Full Text] [Related]
51. Effects of neuropeptides on human lung and breast cancer cells.
Bunn PA; Dienhart DG; Chan D; Tagawa M; Jewett P
J Natl Cancer Inst Monogr; 1992; (13):145-51. PubMed ID: 1389687
[TBL] [Abstract][Full Text] [Related]
52. Bombesin-related peptides induce calcium mobilization in a subset of human small cell lung cancer cell lines.
Heikkila R; Trepel JB; Cuttitta F; Neckers LM; Sausville EA
J Biol Chem; 1987 Dec; 262(34):16456-60. PubMed ID: 2824495
[TBL] [Abstract][Full Text] [Related]
53. Bombesin and bombesin antagonists: studies in Swiss 3T3 cells and human small cell lung cancer.
Woll PJ; Rozengurt E
Br J Cancer; 1988 Jun; 57(6):579-86. PubMed ID: 2841962
[TBL] [Abstract][Full Text] [Related]
54. Bombesin specifically induces intracellular calcium mobilization via gastrin-releasing peptide receptors in human prostate cancer cells.
Aprikian AG; Han K; Chevalier S; Bazinet M; Viallet J
J Mol Endocrinol; 1996 Jun; 16(3):297-306. PubMed ID: 8782088
[TBL] [Abstract][Full Text] [Related]
55. A novel bombesin receptor antagonist inhibits autocrine signals in a small cell lung carcinoma cell line.
Trepel JB; Moyer JD; Cuttitta F; Frucht H; Coy DH; Natale RB; Mulshine JL; Jensen RT; Sausville EA
Biochem Biophys Res Commun; 1988 Nov; 156(3):1383-9. PubMed ID: 2847733
[TBL] [Abstract][Full Text] [Related]
56. A peptide that inhibits the mitogenic stimulation of Swiss 3T3 cells by bombesin or vasopressin.
Corps AN; Rees LH; Brown KD
Biochem J; 1985 Nov; 231(3):781-4. PubMed ID: 2416311
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of proliferation of human small cell lung cancer cells expressing an autocrine system for gastrin releasing peptide by antisense oligodeoxynucleotides to gastrin releasing peptide receptor.
Langer DA; Kautzman D; Kane MA
Lung Cancer; 2002 Jun; 36(3):235-42. PubMed ID: 12009231
[TBL] [Abstract][Full Text] [Related]
58. Two bombesin analogues discriminate between neuromedin B- and bombesin-induced calcium flux in a lung cancer cell line.
Ryan RR; Daniel JL; Cowan A
Peptides; 1993; 14(6):1231-5. PubMed ID: 8134305
[TBL] [Abstract][Full Text] [Related]
59. Modulation of bombesin-induced phosphatidylinositol hydrolysis in a small-cell lung-cancer cell line.
Trepel JB; Moyer JD; Heikkila R; Sausville EA
Biochem J; 1988 Oct; 255(2):403-10. PubMed ID: 2849413
[TBL] [Abstract][Full Text] [Related]
60. Gastrin releasing peptide is a selective mitogen for small cell lung carcinoma in vitro.
Weber S; Zuckerman JE; Bostwick DG; Bensch KG; Sikic BI; Raffin TA
J Clin Invest; 1985 Jan; 75(1):306-9. PubMed ID: 2981251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
